Professional Documents
Culture Documents
ADR Handout
ADR Handout
DEFINITION
- an appreciably harmful or unpleasant reaction resulting from an intervention related to the use of a medicinal
product; adverse effects usually predict hazard from future administration and warrant prevention, or specific
treatment, or alteration of the dosage regimen, or withdrawal of the product.
TERMINOLOGIES
- Medication Error
o Any preventable event that may cause or lead to inappropriate medication use or patient harm while the
medication is in the control of the health care professional, patient, or consumer (NCC MERP)
o Inappropriate use of a drug that may or may not result in harm (Nebeker)
- Side effect
o Any unintended effect of a pharmaceutical product occurring at normal doses, related to the
pharmacology of the drug
- Signal
a. Reported information on a possible causal relation between an adverse event and a drug, the relation being
previously unknown or incompletely documented (Edwards)
MODERATE Change in treatment is required but not Visual disturbance, Muscle tremor,
discontinued, hospitalization may be prolonged or Difficulty with urination, Mood or
a specific treatment is required Mental Alteration
AMMDacanayRPh©2020
LETHAL Lethal reactions are those in which a drug reaction Bleeding from anticoagulants
directly or indirectly caused death. These reactions
are typically severe reactions that were not
detected in time or did not respond to treatment.
Type A: AUGMENTED
- Dose-related reactions
- It can occur either as an extension effect or part of the therapeutic effect or can occur as not part of the intended
therapeutic effect (as a side-effect).
- It has usually a dose-dependent mechanism.
- Subtypes
a. Augmented extension effect
- bradycardia seen in this hypertensive patient was less than 60 and the patient feels some discomfort, then
this is a form of beta-blocker augmented extension effect.
- It is expected, and can be managed with dose reduction or shifting to another class of hypertensive agent.
b. Augmented side effect
- let us say that the same patient experienced bronchospasm as a result of beta-blocker use, this is a form of
an augmented Side-effect.
- The management in this ADR case will have to be shifting to another class of hypertensive agent.
- Phenothiazines or haloperidols used to treat psychiatric conditions may induce extra-pyramidal side
reactions that can be managed with small doses of benztropine or diphenhydramine.
- Anti-cancer drugs that induce nausea and vomiting can be given anti-emetic agents.
Type B: BIZARRE
- Non-dose-related reactions
- this effect can be likened to a hypersensitivity or idiosyncratic reactions.
- It is often unpredictable.
- Unknown mechanism and casualty
- Subtypes:
- Idiosyncratic
a. Unknown Mechanism; Influenced by genetic and environmental factor.
b. Example:
- Sulfonamides causing Stevens-Johnson Syndrome
- Halothane causing acute hepatic necrosis
- Anesthetic drugs causing hyperthermia
- Immunologic Reaction Mechanism
AMMDacanayRPh©2020
TYPE I Occurs after antigen binds onto igE found on the Anaphylaxis , hay fever,
ANAPHYLACTIC REACTION
surfaces of mast cells. The re-exposure of the asthma, urticaria
same allergen could cause cross-linking of the cell-
bound igE -> degranulation (release of histamines,
leukotrienes & prostaglandins)
TYPE II involve the binding of IgG and IgM antibodies to Hemolytic transfusion reactions
CYTOTOXIC REACTION antigens on cell surfaces. and hemolytic disease of
newborns (hemolytic anemia
This induces a cascade of events that leads to cell death and aplastic anemia)
(complement-mediated lysis).
TYPE III result from the formation of antigen-antibody complexes Serum sickness, rheumatoid
IMMUNOCOMPLEX that settle on tissues and organs. In an attempt to arthritis and SLE (Hydralazine,
REACTION remove these complexes, underlying tissue is also Phenytoin, INH, Procainamide)
damaged.
AMMDacanayRPh©2020
Type D: DELAYED
- Time related reactions
- this is seen when a drug used at some earlier time has some adverse effects are observed much later on, such as
affecting the next generation
- Subtypes:
o Carcinogenesis
§ Initiation of cancer formation
o Teratogenesis
§ Congenital malformations
§ Teratogens and its complications
• Methotrexate – CNS and limb malformations
• ACE inhibitors- prolonged renal failure in neonates, decreased skull ossification, renal tubular
dysgenesis
• Anticholinergic drugs – neonatal meconium ileus
• Methimazole- aplasia cutis
• Carbamazepine – neural tube defects
• Cyclophosphamide – CNS malformations, secondary cancer
• Danazol- masculinization of female fetuses
• NSAIDs- constriction of ductus arteriosus, necrotizing enterocolitis
• Lithium- Ebstein anomaly
• Warfarin – Skeletal and CNS defects, Dandy- Walker syndrome
- Pregnancy Categories
AMMDacanayRPh©2020
CATEGORY X "Studies in animals or human beings Category X drugs should not be used
have demonstrated fetal during pregnancy.
abnormalities or there is evidence of
fetal risk based on human experience
or both, and the risk of the use of the
drug in pregnant women clearly
outweighs any possible benefit. The
drug is contraindicated in women who
are or may become pregnant."
AMMDacanayRPh©2020